nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNQ1—type 2 diabetes mellitus	0.497	0.864	CbGaD
Dalfampridine—CYP2E1—type 2 diabetes mellitus	0.0783	0.136	CbGaD
Dalfampridine—KCNH5—peripheral nervous system—type 2 diabetes mellitus	0.00864	0.125	CbGeAlD
Dalfampridine—KCNC1—nerve—type 2 diabetes mellitus	0.00379	0.0548	CbGeAlD
Dalfampridine—KCNA5—artery—type 2 diabetes mellitus	0.00305	0.044	CbGeAlD
Dalfampridine—KCNA7—cardiovascular system—type 2 diabetes mellitus	0.00258	0.0372	CbGeAlD
Dalfampridine—KCNV2—retina—type 2 diabetes mellitus	0.00231	0.0334	CbGeAlD
Dalfampridine—KCNA1—nerve—type 2 diabetes mellitus	0.00226	0.0327	CbGeAlD
Dalfampridine—KCNV1—kidney—type 2 diabetes mellitus	0.00202	0.0291	CbGeAlD
Dalfampridine—KCNG3—cardiovascular system—type 2 diabetes mellitus	0.00186	0.0269	CbGeAlD
Dalfampridine—KCNF1—islet of Langerhans—type 2 diabetes mellitus	0.00164	0.0236	CbGeAlD
Dalfampridine—KCNB1—cardiovascular system—type 2 diabetes mellitus	0.00161	0.0232	CbGeAlD
Dalfampridine—KCNQ4—retina—type 2 diabetes mellitus	0.00157	0.0227	CbGeAlD
Dalfampridine—KCNQ5—retina—type 2 diabetes mellitus	0.00153	0.0221	CbGeAlD
Dalfampridine—KCNA4—cardiovascular system—type 2 diabetes mellitus	0.00152	0.022	CbGeAlD
Dalfampridine—KCNA5—islet of Langerhans—type 2 diabetes mellitus	0.00146	0.0212	CbGeAlD
Dalfampridine—KCND1—cardiovascular system—type 2 diabetes mellitus	0.00138	0.02	CbGeAlD
Dalfampridine—KCNC1—cardiovascular system—type 2 diabetes mellitus	0.00133	0.0192	CbGeAlD
Dalfampridine—KCNA5—retina—type 2 diabetes mellitus	0.00125	0.0181	CbGeAlD
Dalfampridine—KCNC4—adipose tissue—type 2 diabetes mellitus	0.00122	0.0176	CbGeAlD
Dalfampridine—KCNS3—nephron tubule—type 2 diabetes mellitus	0.00115	0.0167	CbGeAlD
Dalfampridine—KCNF1—cortex of kidney—type 2 diabetes mellitus	0.00113	0.0163	CbGeAlD
Dalfampridine—KCND3—islet of Langerhans—type 2 diabetes mellitus	0.00109	0.0157	CbGeAlD
Dalfampridine—KCNA5—cardiovascular system—type 2 diabetes mellitus	0.00106	0.0153	CbGeAlD
Dalfampridine—KCNQ1—islet of Langerhans—type 2 diabetes mellitus	0.00106	0.0152	CbGeAlD
Dalfampridine—KCNH6—nephron tubule—type 2 diabetes mellitus	0.00105	0.0152	CbGeAlD
Dalfampridine—KCNF1—adipose tissue—type 2 diabetes mellitus	0.00104	0.0151	CbGeAlD
Dalfampridine—KCNS3—cardiovascular system—type 2 diabetes mellitus	0.00104	0.015	CbGeAlD
Dalfampridine—KCNQ3—cardiovascular system—type 2 diabetes mellitus	0.00104	0.015	CbGeAlD
Dalfampridine—KCNA5—kidney—type 2 diabetes mellitus	0.00104	0.015	CbGeAlD
Dalfampridine—KCNA5—pancreas—type 2 diabetes mellitus	0.00103	0.0149	CbGeAlD
Dalfampridine—KCNS3—kidney—type 2 diabetes mellitus	0.00101	0.0147	CbGeAlD
Dalfampridine—KCNS3—pancreas—type 2 diabetes mellitus	0.00101	0.0146	CbGeAlD
Dalfampridine—KCNA1—retina—type 2 diabetes mellitus	0.000937	0.0135	CbGeAlD
Dalfampridine—KCNH6—kidney—type 2 diabetes mellitus	0.000926	0.0134	CbGeAlD
Dalfampridine—KCNS3—adipose tissue—type 2 diabetes mellitus	0.000915	0.0132	CbGeAlD
Dalfampridine—KCND2—cardiovascular system—type 2 diabetes mellitus	0.000904	0.0131	CbGeAlD
Dalfampridine—KCND2—adipose tissue—type 2 diabetes mellitus	0.000797	0.0115	CbGeAlD
Dalfampridine—KCND3—cardiovascular system—type 2 diabetes mellitus	0.000788	0.0114	CbGeAlD
Dalfampridine—KCND3—pancreas—type 2 diabetes mellitus	0.000766	0.0111	CbGeAlD
Dalfampridine—KCNQ1—cardiovascular system—type 2 diabetes mellitus	0.000763	0.011	CbGeAlD
Dalfampridine—KCND3—cortex of kidney—type 2 diabetes mellitus	0.000751	0.0108	CbGeAlD
Dalfampridine—KCNQ1—kidney—type 2 diabetes mellitus	0.000747	0.0108	CbGeAlD
Dalfampridine—KCNQ1—pancreas—type 2 diabetes mellitus	0.000742	0.0107	CbGeAlD
Dalfampridine—KCNQ1—cortex of kidney—type 2 diabetes mellitus	0.000727	0.0105	CbGeAlD
Dalfampridine—KCND3—adipose tissue—type 2 diabetes mellitus	0.000695	0.01	CbGeAlD
Dalfampridine—KCNQ1—adipose tissue—type 2 diabetes mellitus	0.000673	0.00972	CbGeAlD
Dalfampridine—KCNS3—liver—type 2 diabetes mellitus	0.000641	0.00926	CbGeAlD
Dalfampridine—KCND3—liver—type 2 diabetes mellitus	0.000487	0.00704	CbGeAlD
Dalfampridine—KCNQ1—liver—type 2 diabetes mellitus	0.000472	0.00682	CbGeAlD
Dalfampridine—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000402	0.00581	CbGeAlD
Dalfampridine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000317	0.00201	CcSEcCtD
Dalfampridine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000317	0.00201	CcSEcCtD
Dalfampridine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000316	0.00201	CcSEcCtD
Dalfampridine—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000316	0.00201	CcSEcCtD
Dalfampridine—Back pain—Valsartan—type 2 diabetes mellitus	0.000315	0.002	CcSEcCtD
Dalfampridine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000315	0.002	CcSEcCtD
Dalfampridine—Back pain—Orlistat—type 2 diabetes mellitus	0.000312	0.00198	CcSEcCtD
Dalfampridine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000311	0.00197	CcSEcCtD
Dalfampridine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000311	0.00197	CcSEcCtD
Dalfampridine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00031	0.00197	CcSEcCtD
Dalfampridine—Angiopathy—Metformin—type 2 diabetes mellitus	0.000309	0.00196	CcSEcCtD
Dalfampridine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000309	0.00196	CcSEcCtD
Dalfampridine—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000308	0.00196	CcSEcCtD
Dalfampridine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000307	0.00195	CcSEcCtD
Dalfampridine—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000307	0.00195	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000305	0.00193	CcSEcCtD
Dalfampridine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000302	0.00192	CcSEcCtD
Dalfampridine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000302	0.00192	CcSEcCtD
Dalfampridine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000302	0.00192	CcSEcCtD
Dalfampridine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000302	0.00191	CcSEcCtD
Dalfampridine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000301	0.00191	CcSEcCtD
Dalfampridine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000301	0.00191	CcSEcCtD
Dalfampridine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000301	0.00191	CcSEcCtD
Dalfampridine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000301	0.00191	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.0003	0.0019	CcSEcCtD
Dalfampridine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.0003	0.0019	CcSEcCtD
Dalfampridine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000298	0.00189	CcSEcCtD
Dalfampridine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000296	0.00188	CcSEcCtD
Dalfampridine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000294	0.00187	CcSEcCtD
Dalfampridine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000292	0.00185	CcSEcCtD
Dalfampridine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000292	0.00185	CcSEcCtD
Dalfampridine—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000291	0.0042	CbGeAlD
Dalfampridine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000291	0.00185	CcSEcCtD
Dalfampridine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000291	0.00185	CcSEcCtD
Dalfampridine—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.00029	0.00184	CcSEcCtD
Dalfampridine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00029	0.00184	CcSEcCtD
Dalfampridine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000288	0.00183	CcSEcCtD
Dalfampridine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000288	0.00183	CcSEcCtD
Dalfampridine—Infection—Gliclazide—type 2 diabetes mellitus	0.000288	0.00183	CcSEcCtD
Dalfampridine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000288	0.00183	CcSEcCtD
Dalfampridine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000287	0.00182	CcSEcCtD
Dalfampridine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000284	0.00181	CcSEcCtD
Dalfampridine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000284	0.0018	CcSEcCtD
Dalfampridine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000284	0.0018	CcSEcCtD
Dalfampridine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000281	0.00179	CcSEcCtD
Dalfampridine—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000281	0.00179	CcSEcCtD
Dalfampridine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000281	0.00178	CcSEcCtD
Dalfampridine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00028	0.00178	CcSEcCtD
Dalfampridine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00028	0.00178	CcSEcCtD
Dalfampridine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000279	0.00177	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000278	0.00177	CcSEcCtD
Dalfampridine—Tremor—Metformin—type 2 diabetes mellitus	0.000278	0.00177	CcSEcCtD
Dalfampridine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000278	0.00176	CcSEcCtD
Dalfampridine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000277	0.00176	CcSEcCtD
Dalfampridine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000277	0.00176	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000276	0.00175	CcSEcCtD
Dalfampridine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000275	0.00174	CcSEcCtD
Dalfampridine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000274	0.00174	CcSEcCtD
Dalfampridine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000273	0.00174	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000272	0.00173	CcSEcCtD
Dalfampridine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000271	0.00172	CcSEcCtD
Dalfampridine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000266	0.00169	CcSEcCtD
Dalfampridine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000266	0.00169	CcSEcCtD
Dalfampridine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000266	0.00169	CcSEcCtD
Dalfampridine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000266	0.00169	CcSEcCtD
Dalfampridine—Infection—Valsartan—type 2 diabetes mellitus	0.000264	0.00168	CcSEcCtD
Dalfampridine—Rash—Glipizide—type 2 diabetes mellitus	0.000264	0.00168	CcSEcCtD
Dalfampridine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000264	0.00168	CcSEcCtD
Dalfampridine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000263	0.00167	CcSEcCtD
Dalfampridine—Headache—Glipizide—type 2 diabetes mellitus	0.000263	0.00167	CcSEcCtD
Dalfampridine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000263	0.00167	CcSEcCtD
Dalfampridine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000262	0.00166	CcSEcCtD
Dalfampridine—Infection—Orlistat—type 2 diabetes mellitus	0.000261	0.00166	CcSEcCtD
Dalfampridine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000261	0.00166	CcSEcCtD
Dalfampridine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00026	0.00165	CcSEcCtD
Dalfampridine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000259	0.00164	CcSEcCtD
Dalfampridine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000258	0.00164	CcSEcCtD
Dalfampridine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000258	0.00164	CcSEcCtD
Dalfampridine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000258	0.00164	CcSEcCtD
Dalfampridine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000258	0.00164	CcSEcCtD
Dalfampridine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000256	0.00163	CcSEcCtD
Dalfampridine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000256	0.00163	CcSEcCtD
Dalfampridine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000255	0.00162	CcSEcCtD
Dalfampridine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000255	0.00162	CcSEcCtD
Dalfampridine—Back pain—Losartan—type 2 diabetes mellitus	0.000255	0.00162	CcSEcCtD
Dalfampridine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000255	0.00162	CcSEcCtD
Dalfampridine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000253	0.00161	CcSEcCtD
Dalfampridine—Chest pain—Metformin—type 2 diabetes mellitus	0.000253	0.0016	CcSEcCtD
Dalfampridine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000252	0.0016	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000251	0.00159	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00025	0.00159	CcSEcCtD
Dalfampridine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000249	0.0036	CbGeAlD
Dalfampridine—Nausea—Glipizide—type 2 diabetes mellitus	0.000249	0.00158	CcSEcCtD
Dalfampridine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000249	0.00158	CcSEcCtD
Dalfampridine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000249	0.00158	CcSEcCtD
Dalfampridine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000248	0.00157	CcSEcCtD
Dalfampridine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000248	0.00157	CcSEcCtD
Dalfampridine—Tremor—Losartan—type 2 diabetes mellitus	0.000247	0.00157	CcSEcCtD
Dalfampridine—Rash—Glimepiride—type 2 diabetes mellitus	0.000247	0.00157	CcSEcCtD
Dalfampridine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000246	0.00156	CcSEcCtD
Dalfampridine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000246	0.00156	CcSEcCtD
Dalfampridine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000246	0.00156	CcSEcCtD
Dalfampridine—Headache—Glimepiride—type 2 diabetes mellitus	0.000245	0.00156	CcSEcCtD
Dalfampridine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000244	0.00155	CcSEcCtD
Dalfampridine—Angioedema—Losartan—type 2 diabetes mellitus	0.000241	0.00153	CcSEcCtD
Dalfampridine—Infection—Metformin—type 2 diabetes mellitus	0.000241	0.00153	CcSEcCtD
Dalfampridine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000241	0.00153	CcSEcCtD
Dalfampridine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000239	0.00152	CcSEcCtD
Dalfampridine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000239	0.00152	CcSEcCtD
Dalfampridine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000239	0.00151	CcSEcCtD
Dalfampridine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000238	0.00151	CcSEcCtD
Dalfampridine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000238	0.00151	CcSEcCtD
Dalfampridine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000238	0.00151	CcSEcCtD
Dalfampridine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000238	0.00151	CcSEcCtD
Dalfampridine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000237	0.00151	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000237	0.0015	CcSEcCtD
Dalfampridine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000236	0.0015	CcSEcCtD
Dalfampridine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000235	0.00149	CcSEcCtD
Dalfampridine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000235	0.00149	CcSEcCtD
Dalfampridine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000234	0.00149	CcSEcCtD
Dalfampridine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000234	0.00149	CcSEcCtD
Dalfampridine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000233	0.00148	CcSEcCtD
Dalfampridine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000232	0.00147	CcSEcCtD
Dalfampridine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000232	0.00147	CcSEcCtD
Dalfampridine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000231	0.00147	CcSEcCtD
Dalfampridine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000231	0.00147	CcSEcCtD
Dalfampridine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00023	0.00146	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00023	0.00146	CcSEcCtD
Dalfampridine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000229	0.00145	CcSEcCtD
Dalfampridine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000228	0.00144	CcSEcCtD
Dalfampridine—Constipation—Valsartan—type 2 diabetes mellitus	0.000228	0.00144	CcSEcCtD
Dalfampridine—Infection—Irbesartan—type 2 diabetes mellitus	0.000227	0.00144	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000227	0.00144	CcSEcCtD
Dalfampridine—Hypotension—Metformin—type 2 diabetes mellitus	0.000226	0.00144	CcSEcCtD
Dalfampridine—Chest pain—Losartan—type 2 diabetes mellitus	0.000225	0.00143	CcSEcCtD
Dalfampridine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000224	0.00142	CcSEcCtD
Dalfampridine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000224	0.00142	CcSEcCtD
Dalfampridine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000224	0.00324	CbGeAlD
Dalfampridine—Anxiety—Losartan—type 2 diabetes mellitus	0.000224	0.00142	CcSEcCtD
Dalfampridine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000222	0.00141	CcSEcCtD
Dalfampridine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000222	0.00141	CcSEcCtD
Dalfampridine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000222	0.00141	CcSEcCtD
Dalfampridine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000221	0.0014	CcSEcCtD
Dalfampridine—CYP2E1—kidney—type 2 diabetes mellitus	0.000219	0.00317	CbGeAlD
Dalfampridine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000218	0.00138	CcSEcCtD
Dalfampridine—Confusional state—Losartan—type 2 diabetes mellitus	0.000217	0.00138	CcSEcCtD
Dalfampridine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000217	0.00138	CcSEcCtD
Dalfampridine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000216	0.00137	CcSEcCtD
Dalfampridine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000215	0.00137	CcSEcCtD
Dalfampridine—Infection—Losartan—type 2 diabetes mellitus	0.000214	0.00136	CcSEcCtD
Dalfampridine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000214	0.00136	CcSEcCtD
Dalfampridine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000214	0.00308	CbGeAlD
Dalfampridine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000213	0.00135	CcSEcCtD
Dalfampridine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000213	0.00135	CcSEcCtD
Dalfampridine—Tremor—Ramipril—type 2 diabetes mellitus	0.000212	0.00134	CcSEcCtD
Dalfampridine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000211	0.00134	CcSEcCtD
Dalfampridine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000211	0.00134	CcSEcCtD
Dalfampridine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00133	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000209	0.00133	CcSEcCtD
Dalfampridine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000209	0.00133	CcSEcCtD
Dalfampridine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000208	0.00132	CcSEcCtD
Dalfampridine—Constipation—Metformin—type 2 diabetes mellitus	0.000207	0.00132	CcSEcCtD
Dalfampridine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000207	0.00131	CcSEcCtD
Dalfampridine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000205	0.0013	CcSEcCtD
Dalfampridine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000205	0.0013	CcSEcCtD
Dalfampridine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000204	0.00129	CcSEcCtD
Dalfampridine—Rash—Glyburide—type 2 diabetes mellitus	0.000203	0.00129	CcSEcCtD
Dalfampridine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000203	0.00129	CcSEcCtD
Dalfampridine—Headache—Glyburide—type 2 diabetes mellitus	0.000202	0.00128	CcSEcCtD
Dalfampridine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000201	0.00128	CcSEcCtD
Dalfampridine—Hypotension—Losartan—type 2 diabetes mellitus	0.000201	0.00128	CcSEcCtD
Dalfampridine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.0002	0.00127	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000197	0.00125	CcSEcCtD
Dalfampridine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000196	0.00124	CcSEcCtD
Dalfampridine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000196	0.00124	CcSEcCtD
Dalfampridine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000196	0.00124	CcSEcCtD
Dalfampridine—Insomnia—Losartan—type 2 diabetes mellitus	0.000195	0.00124	CcSEcCtD
Dalfampridine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000194	0.00123	CcSEcCtD
Dalfampridine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000193	0.00123	CcSEcCtD
Dalfampridine—Urticaria—Metformin—type 2 diabetes mellitus	0.000193	0.00122	CcSEcCtD
Dalfampridine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000193	0.00122	CcSEcCtD
Dalfampridine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000192	0.00122	CcSEcCtD
Dalfampridine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000192	0.00122	CcSEcCtD
Dalfampridine—Nausea—Glyburide—type 2 diabetes mellitus	0.000192	0.00122	CcSEcCtD
Dalfampridine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000192	0.00122	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000191	0.00121	CcSEcCtD
Dalfampridine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000191	0.00121	CcSEcCtD
Dalfampridine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000189	0.0012	CcSEcCtD
Dalfampridine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000189	0.0012	CcSEcCtD
Dalfampridine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000188	0.0012	CcSEcCtD
Dalfampridine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000186	0.00118	CcSEcCtD
Dalfampridine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000185	0.00117	CcSEcCtD
Dalfampridine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000184	0.00117	CcSEcCtD
Dalfampridine—Constipation—Losartan—type 2 diabetes mellitus	0.000184	0.00117	CcSEcCtD
Dalfampridine—Rash—Gliclazide—type 2 diabetes mellitus	0.000183	0.00116	CcSEcCtD
Dalfampridine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000182	0.00116	CcSEcCtD
Dalfampridine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000182	0.00115	CcSEcCtD
Dalfampridine—Headache—Gliclazide—type 2 diabetes mellitus	0.000181	0.00115	CcSEcCtD
Dalfampridine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000181	0.00115	CcSEcCtD
Dalfampridine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000179	0.00114	CcSEcCtD
Dalfampridine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000177	0.00113	CcSEcCtD
Dalfampridine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000176	0.00112	CcSEcCtD
Dalfampridine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000174	0.0011	CcSEcCtD
Dalfampridine—Asthenia—Metformin—type 2 diabetes mellitus	0.000174	0.0011	CcSEcCtD
Dalfampridine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000172	0.00109	CcSEcCtD
Dalfampridine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000172	0.00109	CcSEcCtD
Dalfampridine—Urticaria—Losartan—type 2 diabetes mellitus	0.000171	0.00109	CcSEcCtD
Dalfampridine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000169	0.00107	CcSEcCtD
Dalfampridine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000168	0.00107	CcSEcCtD
Dalfampridine—Rash—Valsartan—type 2 diabetes mellitus	0.000168	0.00107	CcSEcCtD
Dalfampridine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000168	0.00106	CcSEcCtD
Dalfampridine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000167	0.00106	CcSEcCtD
Dalfampridine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000167	0.00106	CcSEcCtD
Dalfampridine—Headache—Valsartan—type 2 diabetes mellitus	0.000167	0.00106	CcSEcCtD
Dalfampridine—Rash—Orlistat—type 2 diabetes mellitus	0.000166	0.00105	CcSEcCtD
Dalfampridine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000166	0.00105	CcSEcCtD
Dalfampridine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000166	0.00105	CcSEcCtD
Dalfampridine—Headache—Orlistat—type 2 diabetes mellitus	0.000165	0.00105	CcSEcCtD
Dalfampridine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000165	0.00104	CcSEcCtD
Dalfampridine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000164	0.00104	CcSEcCtD
Dalfampridine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000162	0.00103	CcSEcCtD
Dalfampridine—Dizziness—Metformin—type 2 diabetes mellitus	0.00016	0.00102	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000159	0.00101	CcSEcCtD
Dalfampridine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000159	0.00101	CcSEcCtD
Dalfampridine—Nausea—Valsartan—type 2 diabetes mellitus	0.000158	0.001	CcSEcCtD
Dalfampridine—Constipation—Ramipril—type 2 diabetes mellitus	0.000158	0.001	CcSEcCtD
Dalfampridine—Nausea—Orlistat—type 2 diabetes mellitus	0.000156	0.000992	CcSEcCtD
Dalfampridine—Asthenia—Losartan—type 2 diabetes mellitus	0.000154	0.00098	CcSEcCtD
Dalfampridine—Vomiting—Metformin—type 2 diabetes mellitus	0.000154	0.000978	CcSEcCtD
Dalfampridine—Rash—Metformin—type 2 diabetes mellitus	0.000153	0.00097	CcSEcCtD
Dalfampridine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000153	0.000969	CcSEcCtD
Dalfampridine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000152	0.000965	CcSEcCtD
Dalfampridine—Headache—Metformin—type 2 diabetes mellitus	0.000152	0.000964	CcSEcCtD
Dalfampridine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000151	0.00096	CcSEcCtD
Dalfampridine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000147	0.000931	CcSEcCtD
Dalfampridine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000145	0.000923	CcSEcCtD
Dalfampridine—Rash—Irbesartan—type 2 diabetes mellitus	0.000144	0.000915	CcSEcCtD
Dalfampridine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000144	0.000915	CcSEcCtD
Dalfampridine—Nausea—Metformin—type 2 diabetes mellitus	0.000144	0.000914	CcSEcCtD
Dalfampridine—Headache—Irbesartan—type 2 diabetes mellitus	0.000143	0.00091	CcSEcCtD
Dalfampridine—Dizziness—Losartan—type 2 diabetes mellitus	0.000142	0.000903	CcSEcCtD
Dalfampridine—CYP2E1—liver—type 2 diabetes mellitus	0.000139	0.002	CbGeAlD
Dalfampridine—Vomiting—Losartan—type 2 diabetes mellitus	0.000137	0.000869	CcSEcCtD
Dalfampridine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000136	0.000863	CcSEcCtD
Dalfampridine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000136	0.000862	CcSEcCtD
Dalfampridine—Rash—Losartan—type 2 diabetes mellitus	0.000136	0.000861	CcSEcCtD
Dalfampridine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000136	0.000861	CcSEcCtD
Dalfampridine—Headache—Losartan—type 2 diabetes mellitus	0.000135	0.000856	CcSEcCtD
Dalfampridine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000132	0.000841	CcSEcCtD
Dalfampridine—Nausea—Losartan—type 2 diabetes mellitus	0.000128	0.000812	CcSEcCtD
Dalfampridine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000122	0.000775	CcSEcCtD
Dalfampridine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000117	0.000745	CcSEcCtD
Dalfampridine—Rash—Ramipril—type 2 diabetes mellitus	0.000116	0.000739	CcSEcCtD
Dalfampridine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000116	0.000738	CcSEcCtD
Dalfampridine—Headache—Ramipril—type 2 diabetes mellitus	0.000116	0.000734	CcSEcCtD
Dalfampridine—Nausea—Ramipril—type 2 diabetes mellitus	0.00011	0.000696	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.53e-05	7.7e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.53e-05	7.7e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC2A1—type 2 diabetes mellitus	1.53e-05	7.7e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.53e-05	7.7e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.53e-05	7.7e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A2—type 2 diabetes mellitus	1.53e-05	7.7e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.52e-05	7.68e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP3A4—type 2 diabetes mellitus	1.49e-05	7.51e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.49e-05	7.51e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.49e-05	7.51e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GCG—type 2 diabetes mellitus	1.46e-05	7.38e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GCG—type 2 diabetes mellitus	1.46e-05	7.38e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GCG—type 2 diabetes mellitus	1.46e-05	7.38e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.46e-05	7.38e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.46e-05	7.38e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC2A4—type 2 diabetes mellitus	1.46e-05	7.38e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.46e-05	7.38e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.45e-05	7.3e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.45e-05	7.3e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—ADCY5—type 2 diabetes mellitus	1.43e-05	7.22e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.41e-05	7.12e-05	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—type 2 diabetes mellitus	1.41e-05	7.09e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.39e-05	7e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GCG—type 2 diabetes mellitus	1.39e-05	7e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—type 2 diabetes mellitus	1.36e-05	6.85e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—type 2 diabetes mellitus	1.36e-05	6.85e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—INS—type 2 diabetes mellitus	1.33e-05	6.72e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—INS—type 2 diabetes mellitus	1.33e-05	6.72e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—type 2 diabetes mellitus	1.31e-05	6.62e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—type 2 diabetes mellitus	1.31e-05	6.62e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A2—type 2 diabetes mellitus	1.3e-05	6.54e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT2—type 2 diabetes mellitus	1.29e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT2—type 2 diabetes mellitus	1.29e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	1.28e-05	6.45e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP3A4—type 2 diabetes mellitus	1.26e-05	6.38e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.26e-05	6.36e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.26e-05	6.36e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNB3—type 2 diabetes mellitus	1.26e-05	6.36e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNB3—type 2 diabetes mellitus	1.26e-05	6.36e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNB3—type 2 diabetes mellitus	1.26e-05	6.36e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.26e-05	6.36e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—type 2 diabetes mellitus	1.26e-05	6.33e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—type 2 diabetes mellitus	1.26e-05	6.33e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HMOX1—type 2 diabetes mellitus	1.26e-05	6.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	1.25e-05	6.29e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	1.24e-05	6.26e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAT—type 2 diabetes mellitus	1.24e-05	6.25e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAT—type 2 diabetes mellitus	1.24e-05	6.25e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAT—type 2 diabetes mellitus	1.24e-05	6.25e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CALM1—type 2 diabetes mellitus	1.23e-05	6.21e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SRC—type 2 diabetes mellitus	1.21e-05	6.11e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SRC—type 2 diabetes mellitus	1.21e-05	6.11e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOB—type 2 diabetes mellitus	1.2e-05	6.06e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOB—type 2 diabetes mellitus	1.2e-05	6.06e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOB—type 2 diabetes mellitus	1.2e-05	6.06e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GNB3—type 2 diabetes mellitus	1.2e-05	6.03e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.2e-05	6.03e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.19e-05	6e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—type 2 diabetes mellitus	1.18e-05	5.95e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—type 2 diabetes mellitus	1.18e-05	5.95e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAT—type 2 diabetes mellitus	1.17e-05	5.92e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—type 2 diabetes mellitus	1.17e-05	5.9e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—type 2 diabetes mellitus	1.17e-05	5.9e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—type 2 diabetes mellitus	1.17e-05	5.9e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	1.16e-05	5.86e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—PRKCB—type 2 diabetes mellitus	1.16e-05	5.83e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LPL—type 2 diabetes mellitus	1.15e-05	5.79e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—LPL—type 2 diabetes mellitus	1.15e-05	5.79e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—LPL—type 2 diabetes mellitus	1.15e-05	5.79e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOB—type 2 diabetes mellitus	1.14e-05	5.75e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ADCY5—type 2 diabetes mellitus	1.12e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ADCY5—type 2 diabetes mellitus	1.12e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ADCY5—type 2 diabetes mellitus	1.12e-05	5.67e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GPX1—type 2 diabetes mellitus	1.12e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GPX1—type 2 diabetes mellitus	1.12e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GPX1—type 2 diabetes mellitus	1.12e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.11e-05	5.59e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RELA—type 2 diabetes mellitus	1.1e-05	5.55e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RELA—type 2 diabetes mellitus	1.1e-05	5.55e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CD36—type 2 diabetes mellitus	1.09e-05	5.5e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CD36—type 2 diabetes mellitus	1.09e-05	5.5e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CD36—type 2 diabetes mellitus	1.09e-05	5.5e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LPL—type 2 diabetes mellitus	1.09e-05	5.49e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.08e-05	5.43e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.08e-05	5.43e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.08e-05	5.43e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.07e-05	5.37e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GPX1—type 2 diabetes mellitus	1.06e-05	5.36e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—type 2 diabetes mellitus	1.06e-05	5.35e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—type 2 diabetes mellitus	1.06e-05	5.35e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	1.05e-05	5.32e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CD36—type 2 diabetes mellitus	1.03e-05	5.22e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—type 2 diabetes mellitus	1.03e-05	5.21e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—type 2 diabetes mellitus	1.03e-05	5.21e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—type 2 diabetes mellitus	1.03e-05	5.21e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.02e-05	5.15e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARA—type 2 diabetes mellitus	1.01e-05	5.12e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARA—type 2 diabetes mellitus	1.01e-05	5.12e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARA—type 2 diabetes mellitus	1.01e-05	5.12e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—type 2 diabetes mellitus	9.94e-06	5.01e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AGT—type 2 diabetes mellitus	9.82e-06	4.95e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AGT—type 2 diabetes mellitus	9.82e-06	4.95e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AGT—type 2 diabetes mellitus	9.82e-06	4.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	9.8e-06	4.94e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—type 2 diabetes mellitus	9.8e-06	4.94e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CALM1—type 2 diabetes mellitus	9.66e-06	4.87e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CALM1—type 2 diabetes mellitus	9.66e-06	4.87e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CALM1—type 2 diabetes mellitus	9.66e-06	4.87e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—type 2 diabetes mellitus	9.62e-06	4.85e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—type 2 diabetes mellitus	9.62e-06	4.85e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—type 2 diabetes mellitus	9.62e-06	4.85e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARA—type 2 diabetes mellitus	9.61e-06	4.85e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOA1—type 2 diabetes mellitus	9.51e-06	4.8e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOA1—type 2 diabetes mellitus	9.51e-06	4.8e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOA1—type 2 diabetes mellitus	9.51e-06	4.8e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—type 2 diabetes mellitus	9.37e-06	4.73e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—type 2 diabetes mellitus	9.37e-06	4.73e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AGT—type 2 diabetes mellitus	9.31e-06	4.7e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NFKB1—type 2 diabetes mellitus	9.27e-06	4.68e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NFKB1—type 2 diabetes mellitus	9.27e-06	4.68e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CALM1—type 2 diabetes mellitus	9.16e-06	4.62e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—type 2 diabetes mellitus	9.12e-06	4.6e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	9.03e-06	4.56e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOA1—type 2 diabetes mellitus	9.02e-06	4.55e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SRC—type 2 diabetes mellitus	8.64e-06	4.36e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SRC—type 2 diabetes mellitus	8.64e-06	4.36e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—type 2 diabetes mellitus	8.42e-06	4.24e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—type 2 diabetes mellitus	8.42e-06	4.24e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—type 2 diabetes mellitus	8.38e-06	4.23e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—type 2 diabetes mellitus	8.38e-06	4.23e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—type 2 diabetes mellitus	8.38e-06	4.23e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—INS—type 2 diabetes mellitus	8.22e-06	4.15e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—INS—type 2 diabetes mellitus	8.22e-06	4.15e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—INS—type 2 diabetes mellitus	8.22e-06	4.15e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—type 2 diabetes mellitus	8.16e-06	4.11e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—type 2 diabetes mellitus	8.16e-06	4.11e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—type 2 diabetes mellitus	7.95e-06	4.01e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—INS—type 2 diabetes mellitus	7.79e-06	3.93e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—type 2 diabetes mellitus	7.72e-06	3.9e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—type 2 diabetes mellitus	7.72e-06	3.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BHMT—type 2 diabetes mellitus	7.58e-06	3.82e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—type 2 diabetes mellitus	7.57e-06	3.82e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—type 2 diabetes mellitus	7.57e-06	3.82e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—type 2 diabetes mellitus	7.54e-06	3.8e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—type 2 diabetes mellitus	7.54e-06	3.8e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—type 2 diabetes mellitus	7.54e-06	3.8e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	7.29e-06	3.68e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—type 2 diabetes mellitus	7.21e-06	3.64e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—type 2 diabetes mellitus	7.21e-06	3.64e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—type 2 diabetes mellitus	7.21e-06	3.64e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3R1—type 2 diabetes mellitus	7.21e-06	3.64e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—type 2 diabetes mellitus	7.21e-06	3.64e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—type 2 diabetes mellitus	7.21e-06	3.64e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.21e-06	3.64e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.21e-06	3.64e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—type 2 diabetes mellitus	7.15e-06	3.6e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—type 2 diabetes mellitus	6.84e-06	3.45e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.84e-06	3.45e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AANAT—type 2 diabetes mellitus	6.62e-06	3.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGDS—type 2 diabetes mellitus	6.62e-06	3.34e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—type 2 diabetes mellitus	6.59e-06	3.33e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—type 2 diabetes mellitus	6.59e-06	3.33e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—type 2 diabetes mellitus	6.59e-06	3.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CDO1—type 2 diabetes mellitus	6.28e-06	3.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPD2—type 2 diabetes mellitus	6.28e-06	3.17e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—type 2 diabetes mellitus	6.25e-06	3.15e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AK1—type 2 diabetes mellitus	5.99e-06	3.02e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—type 2 diabetes mellitus	5.82e-06	2.94e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—type 2 diabetes mellitus	5.82e-06	2.94e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A4—type 2 diabetes mellitus	5.53e-06	2.79e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MAT1A—type 2 diabetes mellitus	5.53e-06	2.79e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—type 2 diabetes mellitus	5.37e-06	2.71e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—type 2 diabetes mellitus	5.37e-06	2.71e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—G6PC—type 2 diabetes mellitus	5.34e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ND1—type 2 diabetes mellitus	5.34e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HBA2—type 2 diabetes mellitus	5.34e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.34e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENPP1—type 2 diabetes mellitus	5.34e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCGR—type 2 diabetes mellitus	5.17e-06	2.61e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—OXCT1—type 2 diabetes mellitus	4.88e-06	2.46e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYTB—type 2 diabetes mellitus	4.88e-06	2.46e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SRD5A1—type 2 diabetes mellitus	4.76e-06	2.4e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD17B3—type 2 diabetes mellitus	4.54e-06	2.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STAR—type 2 diabetes mellitus	4.54e-06	2.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACACA—type 2 diabetes mellitus	4.54e-06	2.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCC8—type 2 diabetes mellitus	4.35e-06	2.2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CBS—type 2 diabetes mellitus	4.35e-06	2.2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COX2—type 2 diabetes mellitus	4.19e-06	2.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A2—type 2 diabetes mellitus	4.19e-06	2.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA6—type 2 diabetes mellitus	4.12e-06	2.08e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UCP3—type 2 diabetes mellitus	4.05e-06	2.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UCP2—type 2 diabetes mellitus	4.05e-06	2.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD11B1—type 2 diabetes mellitus	4.05e-06	2.04e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PCK1—type 2 diabetes mellitus	3.8e-06	1.92e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HK1—type 2 diabetes mellitus	3.56e-06	1.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.44e-06	1.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPA—type 2 diabetes mellitus	3.44e-06	1.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.44e-06	1.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCKR—type 2 diabetes mellitus	3.44e-06	1.74e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—type 2 diabetes mellitus	3.31e-06	1.67e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—type 2 diabetes mellitus	3.31e-06	1.67e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—type 2 diabetes mellitus	3.31e-06	1.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDOB—type 2 diabetes mellitus	3.3e-06	1.66e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—type 2 diabetes mellitus	3.14e-06	1.58e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLP1R—type 2 diabetes mellitus	3.07e-06	1.55e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.86e-06	1.44e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CPT1A—type 2 diabetes mellitus	2.81e-06	1.41e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTR—type 2 diabetes mellitus	2.81e-06	1.41e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAMPT—type 2 diabetes mellitus	2.75e-06	1.39e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HBA1—type 2 diabetes mellitus	2.73e-06	1.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LIPC—type 2 diabetes mellitus	2.73e-06	1.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCK—type 2 diabetes mellitus	2.73e-06	1.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.72e-06	1.37e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.67e-06	1.35e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	2.64e-06	1.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	2.45e-06	1.24e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	2.45e-06	1.24e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	2.45e-06	1.24e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	2.41e-06	1.21e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	2.39e-06	1.2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.33e-06	1.18e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.22e-06	1.12e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.22e-06	1.12e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.16e-06	1.09e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.13e-06	1.07e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	2.13e-06	1.07e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.83e-06	9.24e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	1.83e-06	9.24e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	1.82e-06	9.2e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	1.8e-06	9.08e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	1.75e-06	8.81e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	1.7e-06	8.57e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	1.67e-06	8.41e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	1.63e-06	8.24e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	1.63e-06	8.21e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	1.58e-06	7.99e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.57e-06	7.89e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	1.5e-06	7.58e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	1.47e-06	7.43e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	1.43e-06	7.2e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	1.4e-06	7.08e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	1.4e-06	7.05e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	1.38e-06	6.97e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	1.22e-06	6.14e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	1.19e-06	6.03e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	1.1e-06	5.52e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	1.05e-06	5.28e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.05e-06	5.28e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	9.58e-07	4.83e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	4.82e-07	2.43e-06	CbGpPWpGaD
